STEPHANIE BELLCOCK: Open Payments
NPI 1790073740 · LAKE CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 14 payments from 7 companies in 2025. Trend: 2023 $281 · 2024 $324 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Lilly USA, LLC | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
Products named: CAPLYTA, MOUNJARO, Jornay PM, INVEGA SUSTENNA, GARDASIL 9, EVENITY, Ozempic, SPRAVATO.
Industry payments across IA — which companies pay providers there.
